换一批
换一批First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews.
第一作者：
Rongrong,Wu
第一单位：
Department of Radiology, The First People's Hospital of Yunnan Province/Affiliated Hospital of Kunming University of Science and Technology and Departments of.
作者：
主题词
人类(Humans);男(雄)性(Male);中年人(Middle Aged);抗肿瘤药(Antineoplastic Agents);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors)
DOI
10.1097/CAD.0000000000001408
PMID
36730620
发布时间
2023-02-16
- 浏览0
Anti-cancer drugs
294-301页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
